Clinical Trials on Ovarian, Fallopian Tube and Peritoneal Cancer
Total 3224 results
-
TakedaCompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CancerJapan
-
National Cancer Institute (NCI)TerminatedFallopian Tube Neoplasms | Peritoneal Neoplasms | Epithelial Ovarian CancerUnited States
-
Millennium Pharmaceuticals, Inc.CompletedFallopian Tube Cancer | Breast Carcinoma | Ovarian Carcinoma | Peritoneal CancerUnited States
-
Centre Francois BaclesseCompletedFallopian Tube Cancer | Carcinoma of the Ovary | Peritoneal Serous-type Advanced StageFrance
-
Sutro Biopharma, Inc.Active, not recruitingOvarian Cancer | Fallopian Tube Cancer | Ovarian Carcinoma | Ovary Cancer | Primary Peritoneal CarcinomaUnited States
-
ARCAGY/ GINECO GROUPAstraZenecaCompletedFallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal CancerFrance
-
National Cancer Institute (NCI)NRG Oncology; Canadian Cancer Trials GroupActive, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Ovarian Clear Cell Adenocarcinoma | Fallopian Tube Transitional Cell Carcinoma | Ovarian... and other conditionsUnited States, Canada, Puerto Rico, Korea, Republic of, Japan
-
Memorial Sloan Kettering Cancer CenterCompletedOvarian Cancer | Primary Peritoneal | Fallopian TubeUnited States
-
ImmunoGen, Inc.Active, not recruitingOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States, France, Belgium, Spain, Ireland, Italy, Australia, Canada
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)RecruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Clear Cell Adenocarcinoma | Fallopian Tube Clear Cell Adenocarcinoma | Fallopian Tube Endometrioid Adenocarcinoma | Fallopian Tube Serous Adenocarcinoma and other conditionsUnited States
-
Mersana TherapeuticsGOG Foundation; European Network of Gynaecological Oncological Trial Groups...TerminatedUpifitamab Rilsodotin Maintenance in Platinum-Sensitive Recurrent Ovarian Cancer (UP-NEXT) (UP-NEXT)Fallopian Tube Cancer | Primary Peritoneal Cancer | High Grade Serous Ovarian CancerUnited States, Australia, Canada
-
University Health Network, TorontoGlaxoSmithKlineRecruitingOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cancer | High Grade Serous Cancer | High Grade Endometrioid CancerCanada
-
TakedaCompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CancerJapan
-
Asan Medical CenterRecruitingCervical Cancer | Ovarian Cancer | Fallopian Tube Cancer | Endometrial Cancer | Peritoneal CancerKorea, Republic of
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingMalignant Solid Neoplasm | Ovarian Endometrioid Adenocarcinoma | Ovarian Undifferentiated Carcinoma | Cervical Adenocarcinoma | Cervical Adenosquamous Carcinoma | Malignant Peritoneal Neoplasm | Endometrial Clear Cell Adenocarcinoma | Endometrial Endometrioid Adenocarcinoma | Endometrial Mixed Cell... and other conditionsUnited States
-
Masonic Cancer Center, University of MinnesotaNational Cancer Institute (NCI)Not yet recruitingGynecologic Cancer | Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity Cancer
-
Precision TherapeuticsTerminatedCervical Cancer | Uterine Neoplasms | Ovarian Cancer | Fallopian Tube Cancer | Vulvar Cancer | Endometrial Cancer | Vaginal Cancer | Peritoneal CancerUnited States
-
AstraZenecaCompleted
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedMelanoma | Malignant Mesothelioma | Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Uterine Corpus Carcinoma | Ovarian Clear Cell Cystadenocarcinoma | Ovarian Serous Cystadenocarcinoma | Gestational Trophoblastic Tumor | Cervical Adenocarcinoma and other conditionsUnited States
-
Floor Backes, MDActive, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Endometrial Carcinoma | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Platinum-Resistant Ovarian CarcinomaUnited States
-
RemeGen Co., Ltd.Not yet recruitingPrimary Peritoneal Cancer | Fallopian Tube | Epithelial OvarianChina
-
Haider MahdiPfizer; Zenith EpigeneticsRecruitingOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States
-
Yale UniversityR-Pharm-US, LLCCompletedFallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Lance Armstrong FoundationActive, not recruitingOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States
-
Canadian Cancer Trials GroupNational Cancer Institute (NCI); Cancer Research UK; Grupo Español de Investigación... and other collaboratorsCompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal Cavity Cancer | Metastatic CancerCanada, Spain, United States, United Kingdom
-
Avenge Bio, IncTerminatedFallopian Tube Cancer | Primary Peritoneal Cavity Cancer | Primary Peritoneal Carcinoma | Neoplasm, Ovarian | Adenocarcinoma Ovary | Serous Adenocarcinoma of Ovary | Serous Adenocarcinoma of Primary Peritoneum | High Grade Serous AdenocarcinomaUnited States
-
University of ChicagoNational Cancer Institute (NCI)CompletedMale Breast Cancer | Stage IV Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Recurrent Ovarian Epithelial Cancer | Recurrent Primary Peritoneal Cavity Cancer | Recurrent Fallopian Tube CancerUnited States
-
AA SecordMerck Sharp & Dohme LLCCompletedFallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal Cancer | Gynecologic Neoplasms | Uterine Endometrial CancerUnited States
-
National Cancer Institute (NCI)CompletedCancer | Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Ovarian Clear Cell Adenocarcinoma | Ovarian Mucinous Adenocarcinoma | Fallopian Tube... and other conditionsUnited States
-
University of Colorado, DenverImmunoGen, Inc.RecruitingFallopian Tube Cancer | Peritoneal Cancer | Ovary CancerUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal CarcinomaUnited States
-
Hansoh BioMedical R&D CompanyRecruitingOvarian Cancer | Fallopian Tube Cancer | Endometrial Cancer | Primary Peritoneal CancerChina
-
University of MinnesotaCompletedFallopian Tube Cancer | Recurrent Ovarian Cancer | Stage IV Ovarian Cancer | Stage III Ovarian CancerUnited States
-
University of PennsylvaniaNational Cancer Institute (NCI); Alliance for Cancer Gene Therapy; OvaCure Fundation and other collaboratorsTerminatedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CarcinomaUnited States
-
Genelux CorporationGOG FoundationRecruitingFallopian Tube Cancer | Platinum-resistant Ovarian Cancer | Platinum-refractory Ovarian Cancer | Primary Peritoneal Cancer | High-grade Serous Ovarian Cancer | Endometrioid Ovarian Cancer | Ovarian Clear Cell CarcinomaUnited States
-
CelgeneTerminatedOvarian Neoplasms | Fallopian Tube Neoplasms | Peritoneal NeoplasmsUnited States
-
National Cancer Institute (NCI)NRG OncologyCompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Serous Cystadenocarcinoma | Ovarian Clear Cell Adenocarcinoma | Ovarian Mucinous... and other conditionsUnited States
-
AGO Study GroupCompletedFallopian Tube Neoplasms | Peritoneal Neoplasms | Ovarian CancerGermany
-
Andrea JewellUniversity of Kansas Medical CenterRecruitingOvarian Cancer | Fallopian Tube Cancer | Epithelial Ovarian CancerUnited States
-
AGO Study GroupCompletedOvarian Cancer | Fallopian Tube CancerGermany
-
Critical Outcome Technologies Inc.M.D. Anderson Cancer Center; Northwestern Memorial HospitalUnknownCervical Cancer | Head and Neck Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Fallopian Tube Cancer | Lung Cancer | Endometrial Cancer | Peritoneal Cancer | HNSCCUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cancer | Malignant Neoplasms of Female Genital OrgansUnited States
-
Tesaro, Inc.Merck Sharp & Dohme LLCCompletedNeoplasms | Breast Cancer | Advanced Breast Cancer | Ovarian Cancer | Fallopian Tube Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Peritoneal Cancer | Stage IV Breast CancerUnited States
-
Columbia UniversityTerminatedFallopian Tube Cancer | Recurrent Ovarian CancerUnited States
-
National Cancer Institute, NaplesMario Negri Institute for Pharmacological ResearchRecruiting
-
Jonsson Comprehensive Cancer CenterMerck Sharp & Dohme LLCActive, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal CarcinomaUnited States
-
Peter MacCallum Cancer Centre, AustraliaActive, not recruitingOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CarcinomaAustralia
-
Sutro Biopharma, Inc.Active, not recruitingOvarian Cancer | Fallopian Tube Cancer | Endometrial Cancer | Ovarian Carcinoma | Endometrioid Adenocarcinoma | Ovary Cancer | Primary Peritoneal CarcinomaUnited States, Spain